Related references
Note: Only part of the references are listed.The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC
Sebastian Marwitz et al.
FRONTIERS IN ONCOLOGY (2020)
Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle et al.
IMMUNITY (2019)
Complementing the Cancer-Immunity Cycle
Ruben Pio et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
Jared M. Newton et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tissue Site and the Cancer Immunity Cycle
Brendan L. Horton et al.
TRENDS IN CANCER (2019)
Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment
Mark A. J. Gorris et al.
JOURNAL OF IMMUNOLOGY (2018)
A Believer's Overview of Cancer Immunosurveillance and Immunotherapy
Olivera J. Finn
JOURNAL OF IMMUNOLOGY (2018)
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy
Si-Pei Wu et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer
Souptik Barua et al.
LUNG CANCER (2018)
TGF beta pathway inhibition in the treatment of non-small cell lung cancer
Pinar O. Eser et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
Young Kwang Chae et al.
SCIENTIFIC REPORTS (2018)
Resolving the Combinatorial Complexity of Smad Protein Complex Formation and Its Link to Gene Expression
Philippe Lucarelli et al.
CELL SYSTEMS (2018)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed et al.
CELL (2018)
TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
Ankur Chakravarthy et al.
NATURE COMMUNICATIONS (2018)
Multispectral imaging reveals hyper active TGF-β signaling in colorectal cancer
Lei Yang et al.
CANCER BIOLOGY & THERAPY (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
Sadna Budhu et al.
SCIENCE SIGNALING (2017)
Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
Shomyseh Sanjabi et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Takahiro Tsujikawa et al.
CELL REPORTS (2017)
Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
Sadna Budhu et al.
SCIENCE SIGNALING (2017)
Multiparametric immune profiling in HPV-oral squamous cell cancer
Zipei Feng et al.
JCI INSIGHT (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation
Xing Ke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion
Sebastian Marwitz et al.
CANCER RESEARCH (2016)
TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
Benjamin V. Park et al.
CANCER DISCOVERY (2016)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3
Thomas Schneider et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
Share Paper
